Arthrosi's gout drug financed with $75 million Series D
The U.S. company Arthrosi Therapeutics has bagged $75 million in a Series D round to fund the clinical development of a small molecule drug for chronic gout.
Stay updated with breaking news from Financing Round. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
The U.S. company Arthrosi Therapeutics has bagged $75 million in a Series D round to fund the clinical development of a small molecule drug for chronic gout.
Finqware, a fintech startup that developed integration and open banking applications, has launched a new financing round through which it aims to raise EUR3 million.
Intermountain Healthcare and University Hospitals join forces to invest $20 million in Axuall, a clinical workforce intelligence company.
A biotech advancing small molecule antibiotics through preclinical studies has closed its seed financing round of €1.2million ($1.3million) from Boehringer Ingelheim Venture Fund (BIVF) and High-Tech Gründerfonds (HTGF).
Latest news on Cancer Treatment including updates on radiotherapy, chemotherapy, immunotherapy, funding, trials and developments.